PL2501380T3 - Powolny wlew sulkardyny i jej soli - Google Patents

Powolny wlew sulkardyny i jej soli

Info

Publication number
PL2501380T3
PL2501380T3 PL10832056T PL10832056T PL2501380T3 PL 2501380 T3 PL2501380 T3 PL 2501380T3 PL 10832056 T PL10832056 T PL 10832056T PL 10832056 T PL10832056 T PL 10832056T PL 2501380 T3 PL2501380 T3 PL 2501380T3
Authority
PL
Poland
Prior art keywords
sulcardine
salts
slow infusion
infusion
slow
Prior art date
Application number
PL10832056T
Other languages
English (en)
Inventor
Gary T Elliott
Yiping Wang
Donglu Bai
Original Assignee
Huya Bioscience Int Llc
Shanghai Inst Materia Medica Cas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huya Bioscience Int Llc, Shanghai Inst Materia Medica Cas filed Critical Huya Bioscience Int Llc
Publication of PL2501380T3 publication Critical patent/PL2501380T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10832056T 2009-11-17 2010-11-16 Powolny wlew sulkardyny i jej soli PL2501380T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26192709P 2009-11-17 2009-11-17
PCT/US2010/056849 WO2011062903A2 (en) 2009-11-17 2010-11-16 Slow infusion of sulcardine and its salts
EP10832056.5A EP2501380B1 (en) 2009-11-17 2010-11-16 Slow infusion of sulcardine and its salts

Publications (1)

Publication Number Publication Date
PL2501380T3 true PL2501380T3 (pl) 2016-08-31

Family

ID=44060289

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10832056T PL2501380T3 (pl) 2009-11-17 2010-11-16 Powolny wlew sulkardyny i jej soli

Country Status (7)

Country Link
US (1) US8637566B2 (pl)
EP (1) EP2501380B1 (pl)
JP (2) JP6116907B2 (pl)
CN (1) CN102869357A (pl)
ES (1) ES2569123T3 (pl)
PL (1) PL2501380T3 (pl)
WO (1) WO2011062903A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE060876T2 (hu) * 2009-11-17 2023-04-28 Huyabio Int Llc Szulkardin alkalmazása atriális fibrilláció kezelésére
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts
WO2020123824A1 (en) 2018-12-13 2020-06-18 Huya Bioscience International, Llc Sulcardine administration for treatment of acute atrial fibrillation
SG11202108160YA (en) * 2019-01-29 2021-08-30 Huya Bioscience International Llc Sulcardine salts
CN112516136B (zh) * 2019-09-17 2024-03-01 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
IL298907A (en) * 2020-06-12 2023-02-01 Huyabio Int Llc Administering sulcardin for the treatment of acute atrial fibrillation
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
HUE060876T2 (hu) * 2009-11-17 2023-04-28 Huyabio Int Llc Szulkardin alkalmazása atriális fibrilláció kezelésére
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts

Also Published As

Publication number Publication date
US20120245214A1 (en) 2012-09-27
EP2501380A2 (en) 2012-09-26
EP2501380B1 (en) 2016-01-27
WO2011062903A9 (en) 2011-09-09
JP6116907B2 (ja) 2017-04-19
CN102869357A (zh) 2013-01-09
US8637566B2 (en) 2014-01-28
JP2013511472A (ja) 2013-04-04
JP6173391B2 (ja) 2017-08-02
ES2569123T3 (es) 2016-05-06
EP2501380A4 (en) 2013-05-22
WO2011062903A2 (en) 2011-05-26
JP2016014034A (ja) 2016-01-28

Similar Documents

Publication Publication Date Title
GB2482092B (en) Patient interface and aspects thereof
ZA201304280B (en) Treatment of jak2-mediated conditions
SG10201405568UA (en) 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
GB201210075D0 (en) Patient interface and aspects thereof
HK1178149A1 (en) Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4---
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
EP2536283A4 (en) PHENYLHETEROARYL DERIVATIVES AND USE METHOD THEREFOR
EP2464227A4 (en) COMPOUNDS AND METHODS OF USE
EP2548859A4 (en) PREPARATION OF METHYL-D3-AMINE AND SALTS THEREOF
GB0915515D0 (en) Treatment of vasculoproliferative conditions
EP2516404A4 (en) PREPARATION OF BENDAMUSTINE AND ITS SALTS
GB201018124D0 (en) Polymorphs and salts
ZA201209666B (en) Salts and polymorhs of dexrabeprazole
EP2470542A4 (en) PREPARATION OF SITAGLIPTIN AND SALTS THEREOF
PL2501380T3 (pl) Powolny wlew sulkardyny i jej soli
EP2265586A4 (en) PREPARATION OF MONTELUKAST AND ITS SALTS
IL213973A0 (en) Salt of tetrahydrotriazolopyridine derivative and crystal thereof
EP2490541A4 (en) 2-SUBSTITUTED ETHYL HYLTHIAZONE DERIVATIVES AND THEIR USE
GB0906195D0 (en) Needle and syringe
ZA201207945B (en) Salts of dexlansoprazole and their preparation
EG26793A (en) Medical Injector
ZA201106884B (en) Process for the preparation of doxazosin and salts thereof
EP2404631A4 (en) MEDICAL NEEDLE
HU0900178D0 (en) Stronger paper-pallet with use of simple geometrical structure
EP2776462A4 (en) INDOLALKYLAMINO WITHASTEROID CONJUGATES AND USE METHOD THEREFOR